01-17-2019, Mainz, Germany
SCHOTT completes portfolio of ready-to-use adaptiQ® vials with 15R to 30R ISO formats
As the first supplier of nested ready-to-use vials, SCHOTT has expanded its portfolio by large-size ISO formats of 15R, 20R, 25R and 30R vials commercially available for human use (FHU). The vials, which are delivered pre-sterilized in a tub and nest configuration, are manufactured at the company’s production site in USA and are ready to order.
With the rise of biotech and personalized medicine, pharma manufacturers are required to fill different injectable drugs in low volumes and various dosage formats. Subsequently, the demand for ready-to-use (RTU) components and flexible filling technologies is growing. The adaptiQ® RTU vials, now available in 2/4/6/8/10/15/20/25/30 R ISO formats, allow for more flexible manufacturing concepts and more efficient filling. The vials are fixed in a patented nest that securely holds as many as 100 clean and sterile vials in an industry standard tub. Thus eliminating the hassle for pharmaceutical companies to perform non-core processing steps themselves including washing, drying, and sterilization and ultimately lowering the total cost of ownership (TCO).
adaptiQ® vials (pictured here in 20R) are held by the neck and can be processed in the nest or de-nested if required. The freely accessible bottom is key for ensuring perfect temperature transition during lyophilization. Photo: SCHOTT
adaptiQ® vials are made out of FIOLAX® borosilicate glass tubing, the gold standard for packaging pharmaceuticals. The nest design ensures that no glass-to-glass or glass-to-machine contact takes place throughout the entire fill and finish process, reducing the risk of glass breakage while maintaining the high cosmetic quality.
Greater flexibility and efficiency
As part of SCHOTT’s iQ™ platform, the global RTU standard, adaptiQ® vials come in the same nest dimensions and industry-standard tub format as the company’s RTU syringes and cartridges. The standardization allows pharmaceutical companies to run the various containers on the same filling line while minimizing changeover times in between. As a result, pharmaceutical companies gain flexibility in response to the rapidly changing market demands and at the same time ensure patient safety with high quality RTU containers.
SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharma, electronics, optics, life sciences, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. With more than 15,500 employees at production sites and sales offices in 34 countries, the group has a global presence. In the 2017/2018 fiscal year, SCHOTT generated sales of $2.47 billion.
Gregory FCA on behalf of SCHOTT
SCHOTT North America, Inc.
555 Taxter Road
Elmsford, NY 10523
Elmsford, NY 10523